![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Wednesday, May 25, 2016 6:34:14 AM
Here is a surprise launch of the product in UK (Mar'16)
http://www.diagmed.co.uk/new-product-launch-purastat-a-surgical-haemostatic-agent/
"Diagmed Healthcare Ltd is proud to announce a new partnership with 3D Matrix, a global leading company in developing medical devices based on chemically synthesised self-assembling peptides. 3D Matrix are based in Japan and have distributors in US, France, Singapore, China, Brazil and the Netherlands, we at Diagmed Healthcare Ltd are very pleased to be joining their distribution network.
Diagmed Healthcare will be introducing PuraStat to the UK marketplace, which is suitable for use in surgery, endoscopic, and laparoscopic haemostasis sites. Purastat® is a slightly viscous solution of synthetic peptides. Upon contact with blood, the peptide solution instantaneously self-assembles to form a soft gel. This matrix provides a physical barrier to stop bleeding in a variety of surgical and endoscopic indications."
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM
ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM
Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM
Bemax Inc. Positions to Capitalize on Industry Growth with New Improved Quality of Mother's Touch® Disposable Diapers • BMXC • Jun 24, 2024 8:00 AM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM